Emcure Pharmaceuticals Limited’s (EMCURE) Moving Averages Convergence Divergence (MACD) indicator is 99.44, suggesting Emcure Pharmaceuticals Limited is a Sell.
Emcure Pharmaceuticals Limited’s (EMCURE) 20-Day exponential moving average is 2,036.03, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹2,322.35, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) 50-Day exponential moving average is 1,954.03, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹2,322.35, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) 10-Day exponential moving average is 2,134.65, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹2,322.35, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) 100-Day exponential moving average is 1,887.75, while Emcure Pharmaceuticals Limited’s (EMCURE) share price is ₹2,322.35, making it a Buy.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹2,322.35 and Emcure Pharmaceuticals Limited’s (EMCURE) 50-day simple moving average is 1,936.79, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹2,322.35 and Emcure Pharmaceuticals Limited’s (EMCURE) 100-day simple moving average is 1,905.25, creating a Buy signal.
Emcure Pharmaceuticals Limited’s (EMCURE) stock price is ₹2,322.35 and Emcure Pharmaceuticals Limited’s (EMCURE) 200-day simple moving average is 1,745.50, creating a Buy signal.